Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-08-29 Sale | 2024-08-30 6:01 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 70,000 | $72.7 | $5,089,236 | 1,310,119 (Direct) | View |
2024-08-26 Sale | 2024-08-28 6:00 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 95,925 | $73.54 | $7,054,085 | 1,176,240 (Direct) | View |
2024-08-21 Sale | 2024-08-23 6:00 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 121,073 | $75.05 | $9,086,738 | 1,454,844 (Direct) | View |
2024-08-16 Sale | 2024-08-20 6:03 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 18,714 | $75.08 | $1,405,047 | 29,700 (Direct) | View |
2024-06-24 Sale | 2024-06-25 6:04 pm | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 4,462 | $75.57 | $337,193 | 116,600 (Direct) | View |
2024-06-18 Sale | 2024-06-21 6:00 pm | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 20,000 | $75.91 | $1,518,199 | 9,690 (Direct) | View |
2024-03-07 Sale | 2024-03-11 8:33 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 61,277 | $66.07 | $4,048,400 | 1,070,875 (Direct) | View |
2024-03-07 Sale | 2024-03-11 8:33 pm | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO | 23,253 | $66.32 | $1,542,147 | 10,121 (Direct) | View |
2024-03-07 Sale | 2024-03-11 8:32 pm | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 20,477 | $66.09 | $1,353,235 | 7,345 (Direct) | View |
2024-03-07 Sale | 2024-03-11 8:31 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 20,477 | $66.23 | $1,356,110 | 37,045 (Direct) | View |
2024-03-07 Sale | 2024-03-11 8:31 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 10,162 | $66.21 | $672,791 | 27,148 (Direct) | View |
2024-02-27 Sale | 2024-02-28 7:41 pm | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 20,000 | $72.93 | $1,458,650 | 9,611 (Direct) | View |
2024-02-26 Sale | 2024-02-27 8:00 pm | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 7,907 | $69.53 | $549,784 | 0 (Direct) | View |
2024-02-26 Sale | 2024-02-27 8:00 pm | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO | 13,337 | $69.43 | $925,961 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-09-30 Option Award | 2024-10-02 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 246 | $73.17 | 117,108 (Direct) | View |
2024-08-29 Exercise | 2024-08-30 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 70,000 | $12.73 | 1,310,119 (Direct) | View |
2024-08-29 Exercise | 2024-08-30 6:01 pm | N/A 2029-01-07 | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 70,000 | $0 | 1,310,119 (Direct) | View |
2024-08-26 Exercise | 2024-08-28 6:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 95,925 | $17.57 | 1,176,240 (Direct) | View |
2024-08-26 Exercise | 2024-08-28 6:00 pm | N/A 2025-01-02 | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 95,925 | $0 | 1,176,240 (Direct) | View |
2024-08-21 Exercise | 2024-08-23 6:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 121,073 | $17.57 | 1,454,844 (Direct) | View |
2024-08-21 Exercise | 2024-08-23 6:00 pm | N/A 2025-01-02 | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 121,073 | $0 | 1,454,844 (Direct) | View |
2024-08-16 Exercise | 2024-08-20 6:03 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 18,714 | $36.89 | 29,700 (Direct) | View |
2024-08-16 Exercise | 2024-08-20 6:03 pm | N/A 2031-02-22 | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 18,714 | $0 | 29,700 (Direct) | View |
2024-08-12 Option Award | 2024-08-14 6:01 pm | N/A 2034-08-11 | Intra-Cellular Therapies Inc. | ITCI | Narula Sanjeev Executive Vice President & CFO | 52,297 | $0 | 52,297 (Direct) | View |
2024-06-28 Option Award | 2024-07-02 8:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 83 | $68.49 | 11,340 (Direct) | View |
2024-06-28 Option Award | 2024-07-02 8:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 262 | $68.49 | 116,862 (Direct) | View |
2024-06-23 Exercise | 2024-06-25 6:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 1,567 | $0 | 11,257 (Direct) | View |
2024-06-23 Exercise | 2024-06-25 6:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Salas Eduardo Rene Director | 1,567 | $0 | 1,567 (Direct) | View |
2024-06-23 Exercise | 2024-06-25 6:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 1,567 | $0 | 51,229 (Direct) | View |
2024-06-23 Exercise | 2024-06-25 6:04 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 21,567 | $0 | 116,600 (Direct) | View |
2024-06-24 Exercise | 2024-06-25 6:04 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 20,000 | $16.86 | 116,600 (Direct) | View |
2024-06-18 Exercise | 2024-06-21 6:00 pm | N/A 2024-06-30 | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 20,000 | $0 | 9,690 (Direct) | View |
2024-06-18 Exercise | 2024-06-21 6:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 20,000 | $16.86 | 9,690 (Direct) | View |
2024-06-14 Option Award | 2024-06-18 6:02 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Salas Eduardo Rene Director | 7,273 | $0 | 7,273 (Direct) | View |
2024-06-14 Option Award | 2024-06-18 6:02 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 7,273 | $0 | 7,273 (Direct) | View |
2024-06-14 Option Award | 2024-06-18 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 7,273 | $0 | 7,273 (Direct) | View |
2024-06-14 Option Award | 2024-06-18 6:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 7,273 | $0 | 7,273 (Direct) | View |
2024-04-24 Exercise | 2024-04-25 5:08 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 11,382 | $17.57 | 1,287,327 (Direct) | View |
2024-04-24 Exercise | 2024-04-25 5:08 pm | N/A 2024-06-30 | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 20,020 | $0 | 1,287,327 (Direct) | View |
2024-04-24 Exercise | 2024-04-25 5:08 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 8,638 | $16.86 | 1,287,327 (Direct) | View |
2024-03-31 Option Award | 2024-04-02 4:15 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 79 | $69.2 | 9,690 (Direct) | View |
2024-03-31 Option Award | 2024-04-02 4:15 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 260 | $69.2 | 99,495 (Direct) | View |
2024-03-20 Exercise | 2024-03-22 4:12 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 20,000 | $18.56 | 99,235 (Direct) | View |
2024-03-20 Exercise | 2024-03-22 4:12 pm | N/A 2024-03-21 | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 20,000 | $0 | 99,235 (Direct) | View |
2024-03-10 Exercise | 2024-03-11 8:33 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 20,565 | $0 | 1,070,875 (Direct) | View |
2024-03-10 Exercise | 2024-03-11 8:33 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO | 10,121 | $0 | 10,121 (Direct) | View |
2024-03-10 Exercise | 2024-03-11 8:33 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO | 4,539 | $56.73 | 10,121 (Direct) | View |
2024-03-10 Exercise | 2024-03-11 8:32 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 7,345 | $0 | 7,345 (Direct) | View |
2024-03-10 Exercise | 2024-03-11 8:31 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 7,345 | $0 | 37,045 (Direct) | View |
2024-03-10 Exercise | 2024-03-11 8:31 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 7,345 | $0 | 27,148 (Direct) | View |
2024-03-06 Exercise | 2024-03-08 5:59 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 13,132 | $0 | 69,098 (Direct) | View |
2024-03-06 Exercise | 2024-03-08 5:59 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 40,712 | $0 | 1,172,446 (Direct) | View |
2024-03-06 Exercise | 2024-03-08 5:58 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 13,132 | $0 | 39,398 (Direct) | View |
2024-03-06 Exercise | 2024-03-08 5:58 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO | 13,132 | $0 | 39,398 (Direct) | View |
2024-03-06 Exercise | 2024-03-08 5:58 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 13,132 | $0 | 48,886 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 7:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 36,717 | $0 | 36,717 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 7:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO | 26,227 | $0 | 26,227 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 7:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 26,227 | $0 | 26,227 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 7:04 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 26,227 | $0 | 26,227 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 7:02 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 104,909 | $0 | 104,909 (Direct) | View |
2024-02-27 Exercise | 2024-02-28 7:41 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 20,000 | $18.56 | 9,611 (Direct) | View |
2024-02-27 Exercise | 2024-02-28 7:41 pm | N/A 2024-03-21 | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 20,000 | $0 | 9,611 (Direct) | View |
2024-02-23 Exercise | 2024-02-27 8:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 7,907 | $0 | 0 (Direct) | View |
2024-02-26 Exercise | 2024-02-27 8:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO | 5,882 | $36.89 | 0 (Direct) | View |
2024-02-23 Exercise | 2024-02-27 8:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance, CFO | 13,337 | $0 | 0 (Direct) | View |